To determine the neuroprotective properties of a latanoprost acid derivative (ACS67) that donates the gas hydrogen sulfide (H 2 S). METHODS. Ischemia to the rat retina was induced by elevation of intraocular pressure. Electroretinograms (ERGs) were recorded and the retinas analyzed 2 days later by immunohistochemistry, Western blot analysis, and RT-PCR. Hydrogen peroxide (H 2 O 2 ) was used to impose an insult on RGC-5 cells in culture. The nature of the insult to cultures was quantified by the resazurin-reduction assay procedure, staining for reactive oxygen species (ROS) and for apoptosis. ACS67, its sulfurated moiety (ACS1), and latanoprost were tested for both their toxicity and ability to blunt the negative effect of H 2 O 2 on RGC-5 cells. In addition, an assay was used to see whether any of the substances influenced glutathione (GSH) levels in RGC-5 cells. RESULTS. Partial damage to the retina in situ after ischemia was characterized by an alteration of the ERG, a reduction in the retinal localization of specific antigens and a reduction and elevation of defined retinal proteins and mRNAs. Optic nerve axonal proteins were also drastically reduced by ischemia. Most of these changes were significantly blunted by an intravitreal injection of ACS67 directly after ischemia. ACS67, ACS1, and the antioxidant epigallocatechin gallate (EGCG) all stimulated GSH levels and significantly attenuated H 2 O 2 -induced toxicity to RGC-5 cells, whereas latanoprost did not. CONCLUSIONS. ACS67 acts as an H 2 S donor through its donating moiety ACS1 and as a consequence is able to act as a neuroprotectant. (Invest Ophthalmol Vis Sci. 2010;51: 284 -294) DOI:10.1167/iovs.09-3999 O ne of the most potent agents used to lower intraocular pressure in the treatment of glaucoma is the prostaglandin latanoprost (isopropyl ester of latanoprost acid).
O ne of the most potent agents used to lower intraocular pressure in the treatment of glaucoma is the prostaglandin latanoprost (isopropyl ester of latanoprost acid). 1 A derivative of this substance, ACS67, maintains the IOP effectiveness associated with latanoprost 2 but also releases H 2 S through its H 2 S-releasing moiety.
3 H 2 S, produced in biological tissues by cysteine, is now recognized as a signaling molecule that participates in many functions. 4, 5 It is produced by the cystathionine ␤-synthase (CBS) and cystathionine ␥-lyase (CSE) enzymes present in various tissues. 6 H 2 S is implicated in functions as diverse as inflammation, vasodilation, and neuronal survival. 4, 5, 7, 8 Actual concentrations of H 2 S in human, rat, and bovine brain are significant and elicit biological effects at concentrations between 10 and 1000 M. 4,9 -11 H 2 S stimulates the formation of cAMP in neuronal cultures or glial cell lines, 12 is a regulator of the N-methyl-D-aspartate (NMDA) receptor, and is shown to play a part in long-term potentiation. 12 ,13 H 2 S regulates the activities of serotonergic neurons, 14 induces a release of corticotrophin-releasing hormones, 15 activates neuronal calcium channels, 16 increases intracellular glutathione levels, and affects smooth muscle relaxation and vasodilation by acting on K ATP or Cl Ϫ channels. 4, 5, 7 H 2 S is a gas with wide-ranging cytotoxic effects, 10 and recent studies suggest that its negative effect is probably related to its concentration. In homogenates, H 2 S generation is between 1 and 10 picomoles/s/mg protein 17 ; and, given its rapid turnover, the extracellular active sulfide concentration is probably in the low micromolar range. 4 This may explain why agents that donate H 2 S have generally been found in culture studies to protect neurons and other cell types from oxidative stress 9,18 -22 or damage caused by ␤-amyloid to neurons. 23 Moreover, the effect of ischemia-reperfusion insults to the heart and liver are attenuated by H 2 S donors. 18, 24, 25 However, reports from other studies show that H 2 S can be toxic to brain neurons in culture 26 and that it exacerbates the negative effect of ischemia to the cerebral cortex. 27 A derivative of latanoprost, ACS67, belongs to a class of compounds known as dithiolethiones ( Fig. 1 ) which release H 2 S in a long-lasting controlled way. 3 Dithiolethione hybrids of diclofenac, 3, 28, 29 sildenafil, 30 and aspirin 31 have all been shown to maintain their endogenous properties but have additive effects associated with H 2 S. ACS67 is more effective than latanoprost in reducing IOP in rabbits as well as in stimulating cGMP and GSH levels. 2 The ability of ACS67 to increase GSH suggests that the compound has neuroprotective properties. The purpose of this study was therefore to test this hypothesis by deducing whether ACS67 attenuates the negative effect of an ischemic insult to the rat retina in situ. Moreover, studies were conducted on a transformed cell line that exhibited certain characteristics associated with ganglion cells to determine whether ACS67 stimulated the production of glutathione and/or counteracted the influence of oxidative stress induced by H 2 O 2 .
MATERIALS AND METHODS
Animal procedures conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, as approved by the Home Office in the United Kingdom. Rats were housed in a 12-hour lightdark cycle and were provided food and water ad libitum. Adult animals were anesthetized with an intramuscular injection (Hypnorm; Janssen, Grove, UK; 0.3 mL/kg; and diazepam 2.5 mg/kg; CP Pharmaceuticals Ltd., Wrexham, UK) and their ERGs were recorded from both eyes. Chemicals and reagents were from Sigma Chemical Company (Poole, UK). ACS67 and ACS1 were prepared as previously described.
3
Induction of Retinal Ischemia. Ischemia was induced by inserting a 30-gauge needle, connected to a sterile saline reservoir at a certain height, into the anterior chamber of one eye to produce an IOP (determined before use of a mercury manometer) of 120 mm Hg. Ischemia was confirmed by immediate whitening of the fundus which lasted for 50 minutes. Normal body temperature was maintained and monitored both during ischemia and in the recovery period before transfer to animal house conditions. In some instances, 5 L of ACS67 (4 nM) or vehicle (50% DMSO) was injected into the vitreous humor via the limbus directly after ischemia, and these animals were killed after 7 days of reperfusion. Retinas and optic nerves were dissected and analyzed for levels of defined mRNAs and proteins. In some instances, the retinas were fixed and processed for immunohistochemistry.
Electroretinography. ERGs from both eyes were recorded 2 to 3 days before and 5 days after ischemia. The animals were initially dark adapted for at least 6 hours before their flash ERGs were recorded. Pupils were dilated with 1% tropicamide (Smith and Nephew Pharmaceuticals Ltd., Romford, UK) and 2.5% phenylephrine (Smith and Nephew Pharmaceuticals Ltd.). A platinum electrode was placed in contact with the cornea and a reference electrode through the tongue; a grounding electrode was attached to the scruff of the neck. All procedures were performed in dim red light, and the rats were kept warm during and after the procedure. The responses to a 2500 cd/m 2 white light flash (10 s, 0.1 Hz) from a photic stimulator (model PS33-plus; Grass Instrument Divisions, West Warwick, UK) were amplified and averaged by using a 1902 Signal Conditioner/1401 Laboratory Interface; CED, Cambridge, UK). The amplitude of the a-wave was measured from the baseline to the maximum a-wave trough and the b-wave was measured from the maximum a-wave trough to the maximum b-wave peak. Data were analyzed by the Student's unpaired t-test, and P Ͻ 0.05 was considered significant.
Immunohistochemistry.
Freshly dissected retinas 7 days after ischemia were fixed in 2% paraformaldehyde for 40 minutes and 10-m frozen retinal sections produced. Sections were subsequently incubated overnight at 4°C with sheep anti-nNOS antibody (diluted 1:100; donated by Piers Emson, Cambridge University, Cambridge, UK), rabbit anti-GFAP polyclonal antibody (diluted 1:1000; Dako, Ely, UK) or mouse monoclonal anti-Thy-1 monoclonal antibody (clone OX-7, diluted 1:30; a gift of the Dunn School of Pathology, Oxford University, Oxford, UK) and developed with appropriate secondary antibodies conjugated to fluorescein.
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RT-PCR Procedure. The levels of cyclophilin, Thy-1, NF-L, PARP, GFAP, caspase 3, and caspase 8 mRNAs were determined in the retina from rats seven days after ischemia with semiquantitative RT-PCR, as described previously. 33, 34 Briefly, total RNA was isolated, and first-strand cDNA synthesis was performed on 2 g DNase-treated RNA. The individual cDNA species were amplified in a reaction containing an aliquot of cDNA; PCR buffer, 5 mM MgCl 2 for NF-L, caspase 3, and caspase 8, and 4 mM MgCl 2 for all other primers; dNTPs; the relevant primer pairs; and DNA polymerase. Reactions were initiated by incubating at 94°C for 10 minutes and PCRs (94°C, 15 seconds; 52°C, 55°C, or 56°C, 30 seconds; and 72°C, 30 seconds) performed for a suitable number of cycles (26 -28 cycles except in the case of caspase 8 for which the number of cycles was between 32 and 35), followed by a final extension at 72°C for 3 minutes. Interexperimental variation was avoided by performing all amplifications in a single run. PCR reaction products were separated on 1.2% agarose gels with ethidium bromide for visualization. The relative abundance of each PCR product was determined by quantitative analysis of digital photographs of gels (Labworks software; UVP Products, Upland, CA). The sequence and annealing temperatures of the primers used (Gibco Life Technologies, Paisley, Scotland, UK) are shown in Table 1 .
Before semiquantitative amplification of the experimental samples, the amount of cDNA in all the samples was equalized. In addition, the optimal conditions (e.g., Mg 2ϩ concentration and annealing temperature) for each set of primers were determined. Subsequently, cycle-FIGURE 1. A comparison of the structural differences between latanoprost, ACS1, and ACS67. ACS67 is a dithiolethione (ACS1) hybrid together with latanoprost. The dithiolethione molecule generates H 2 S once in a cell. Electrophoresis and Western Blot Analysis. Optic nerves (6 -8 mm long) or retinas from rats 7 days after ischemia were sonicated in 100 L homogenization buffer (20 mM Tris/HCl [pH 7.4], containing 2 mM EDTA, 0.5 mM EGTA, 1% SDS, 0.1 mM phenylmethylsulfonyl fluoride, 50 g/mL aprotinin, 50 g/mL leupeptin, and 50 g/mL pepstatin A) to which an equal volume of sample buffer (62.5 mM Tris/HCl [pH 7.4], containing 4% SDS or sodium dodecyl sulfate, 10% glycerol, 10% mercaptoethanol, and 0.002% bromophenol blue) was added. Optic nerve and retinal samples were boiled for 3 minutes and an aliquot analyzed for total protein content with a bicinchoninic acid protein kit (Sigma-Aldrich).
Retinal proteins from tissues 7 days after ischemia were separated and isolated from RNA (TriReagent kit; Sigma-Aldrich). Proteins from individual retinas were then solubilized in 200 L of homogenization buffer/protease inhibitors solution to which an equal volume of sample buffer was added.
Equal amounts of proteins were fractionated by electrophoresis with 10% polyacrylamide gels containing 0.1% SDS, as described by Laemmli. 35 Proteins were transferred to nitrocellulose and blots were incubated for 3 hours at room temperature with various primary antibodies. Detection was then performed with appropriate biotinylated secondary antibodies. The final nitrocellulose blots were developed with a 0.016% wt/vol solution of 3-amino-9-ethylcarbazole (AEC) in 50 mM sodium acetate (pH 5.0) containing 0.05% (vol/vol) Tween-20 and 0.03% (vol/vol) H 2 O 2 . The colorimetric reaction was stopped with 0.05% sodium azide solution, the blot was scanned at 800 dpi (Perfection 1200u scanner; Epson Ltd., Hemel Hempstead, UK), and quantitative analysis of the detected proteins was performed (Labworks software; UVP Products).
Primary antibodies used were as follows: PARP-1 (1:1000; BD Biosciences, Oxford, UK), actin ( Resazurin Reduction Assay (RRA). The RRA was performed with a kit from Promega. The assay is based on the ability of living cells to convert the redox dye into a florescent product (resorufin; excitation 530 nm, emission 590 nm). 36, 37 Identification of Apoptosis. This assay was performed as described by the manufacturer (Biocolor Ltd., Belfast, Northern Ireland, UK). Briefly, 5 L of the dye was added to the cells in each well of a 96-well plate and incubated for 30 minutes at 37°C. The medium was then removed and the cells were washed twice with PBS before viewing by light microscopy.
Localizing Apoptotic Cells with Hoechst. Cells were fixed in 4% paraformaldehyde and incubated with Hoechst 33258 dye (2.5 g/mL dissolved in distilled water) for 30 minutes at room temperature. Cells with intensely stained nuclei caused by Hoechst affinity for fragmented DNA were defined as cells in the process of apoptosis.
Localization of ROS.
The dye 2Ј,7Ј-dihydroethidium (DHE) was oxidized by superoxide and H 2 O 2 and was used to localize ROS. 38 DHE is nonfluorescent and can passively cross the membrane of live cells. Within the cells, DHE was oxidized by superoxide anion or H 2 O 2 to generated ethidium bromide, which binds to DNA and, when excited, emits red fluorescence that is proportional to the intracellular superoxide anion level. After different treatments, DHE (10g/mL) was added to the culture medium and maintained in the incubator for 30 minutes at 37°C. The coverslips containing the cells were then fixed with 4% paraformaldehyde for 20 minutes. After the coverslips were washed in PBS, they were mounted in PBS containing 1% glycerol, and ROS was detected by intense red fluorescence with an epifluorescence microscope (Carl Zeiss Meditec, Oberkochen, Germany).
Assay of Glutathione.
The assay is based on glutathione-Stransferase (GST) reacting with GSHϩmonochlorobimane (mCB) to form the fluorescent product bimane-glutathione. 39 Briefly, after maintaining cell cultures in 40-mm wells in the presence of different substances for 8 hours approximately 1 ϫ 10 6 RGC-5 cells (collected from two 40 mm wells) were collected and centrifuged at 700g for 10 minutes at 4°C. The pelleted cells were then resuspended in cell lysis buffer (100 L) and after 10 minutes centrifuged at 10,100g for 10 minutes. Supernatant samples (20 L) were transferred to a microplate, and, to each sample, 2 L 20 mM mCB and 4 L of GST 25 U/mL was added. After incubation at 37°C for 15 minutes, fluorescence was measured in a plate reader where the excitation and emission spectra were 380 and 460 nm, respectively. Statistical Analysis. Data, unless stated otherwise, were analyzed for significance with a one-way analysis of variance (ANOVA) followed by a Tukey multiple-comparison test and are expressed as a mean percentage of the control value Ϯ SEM. P Ͻ 0.05 was considered significant.
RESULTS

Effect of ACS67 on Retinal Ischemia-Reperfusion
Elevated IOP-induced ischemia for 50 minutes followed by 5 days of reperfusion caused, on average, a 36% and 63% reduction in the a-and b-wave amplitudes, respectively, in ACS67-treated rats (n ϭ 14). In animals treated with vehicle (n ϭ 14), the reduction in the a-and b-wave amplitudes was approximately 49% and 76%, respectively. The differences in amplitudes of both the a-and b-waves between the two groups of animals were significant. Neither ACS67 nor its vehicle (DMSO) affected the ERG recordings of untreated (nonischemic) eyes (Fig. 2) . Ischemia for 50 minutes followed by 7 days of reperfusion caused a change in the content of selected retinal and optic nerve proteins as shown in Figures 3 and 4 . These data show that ischemia-reperfusion significantly decreased the protein level of NF-L but increased the level of PARP and GFAP proteins in the retina (Fig. 3) . Of importance, the changes in protein levels of NF-L, PARP, and GFAP induced by ischemia were attenuated by ACS67 treatment by 13%, 28%, and 24%, respectively (Fig. 3) . In addition, NF-L and tubulin proteins in the optic nerve were found to decrease by 54% and 42%, respectively, after ischemia-reperfusion (Fig. 4) . The decrease in optic nerve NF-L and tubulin proteins caused by ischemia-reperfusion was significantly nullified in rats treated with ACS67, where the decrease in NF-L and tubulin proteins was 22% and 20%, respectively (Fig. 4) . Ischemia for 50 minutes followed by 7 days of reperfusion also caused changes in the content of selected mRNAs. The mRNA levels (normalized to cyclophilin) of Thy-1 and NF-L in vehicle-treated rat retinas were significantly reduced (Figs. 5) . In contrast, the mRNA levels of caspase 3, caspase 8, PARP, and GFAP were clearly elevated (Figs. 6, 7) . The reduction of Thy-1 and NF-L caused by ischemia was significantly less, 19% and 21%, respectively, when ACS67 was injected into the eye after ischemia. ACS67 treatment, however, did not affect the increased mRNA levels of caspase 8, caspase 3, or PARP caused by ischemia but blunted the increase in GFAP mRNA by 31%.
Analysis of retinal tissues from vehicle-treated animals for the localization of nNOS (neuronal nitric oxide synthase), GFAP, and Thy-1 immunoreactivity 7 days after ischemia showed clear changes compared with the controls. Normal Thy-1 staining in the retinas of the rats was associated with the ganglion cell layer and the whole of the inner plexiform layer (Fig. 8A) . Normal nNOS immunoreactivity was associated with certain amacrine cells and their processes appeared as three defined bands in the inner plexiform layer (Fig. 8D) . Normal GFAP immunoreactivity was primarily associated with astrocytes and end feet of Müller cells in the ganglion cell and nerve fiber layers (Fig. 8G) . Ischemia-reperfusion in vehicle-treated eyes caused a significant thinning of Thy-1 immunoreactivity (Fig. 8B) , a marked elimination of nNOS immunoreactivity (Fig.  8E) , and an intense staining of GFAP in Müller cells throughout the retina (Fig. 8H) . In contrast, in the ischemia/ACS67-treated rats, the reduction of Thy-1 and nNOS immunoreactivity was less pronounced (Figs. 8C, 8F) , and the enhancement of GFAP staining was clearly reduced (Fig. 8I ). This conclusion was reached after analysis of many retinal sections from areas of the retina that were of similar eccentricity.
FIGURE 2.
In these studies, ERGs from both eyes were recorded. One eye was subsequently given ischemia. Five days later, the ERGs from the ischemic and nonischemic eyes were recorded and the percentage changes in the a-and b-wave amplitudes were compared between the ischemic and control eyes. Both the a-and b-wave amplitudes of the ERG were clearly reduced by ischemia-reperfusion (***P Ͻ 0.001 compared with control). Moreover, compared with vehicle, ACS67 significantly attenuated the reduction of the a-and b-wave amplitudes (**P Ͻ 0.01 compared with ischemia). Results are the mean Ϯ SEM, n ϭ 14.
FIGURE 3. NF-L (A), GFAP (B)
, and PARP (C) proteins relative to actin in the nonischemic retina (control) and after ischemia-reperfusion with vehicle or ACS67 treatment. Ischemiareperfusion caused a significant change in the amounts of NF-L, GFAP, and PARP proteins compared with the control (***P Ͻ 0.001). However, treatment with ACS67 significantly (**P Ͻ 0.01) blunted this effect. ACS67 reduced the change in NF-L, GFAP, and PARP proteins caused by ischemia by 14%, 24%, and 28%, respectively. Data are expressed as the mean; error bar, Ϯ SEM (n ϭ 12). 
Studies on RGC-5 Cells in Culture
Figures 9, 10, and 11 show data from RRA viability assays in which RGC-5 cells in culture media were exposed to ACS67, ACS1, or latanoprost (all between 1 and 50 M) or vehicle (DMSO) for 24 hours. It is clear that, even at 20 M, ACS67 and ACS1 had no effect on cell survival. In contrast, latanoprost at concentrations greater than 10 M was toxic. Since it has been shown in previous studies that the viability of RGC-5 cells is dose dependently reduced by H 2 O 2 over a 24-hour period of exposure, 40, 41 it was decided in the present experiments to impose an in insult on RGC-5 cells with 200 M H 2 O 2 . This insult resulted in approximately 30% loss of cell viability over a 24-hour period (Fig. 9) .
With the RRA assay, it was found that ACS1 ( Fig. 9 ) and ACS67 ( Fig. 10) counteracted dose dependently the negative effect of 200 M H 2 O 2 on RGC-5 cells between 10 and 50 M and 5 and 20 M, respectively. In contrast, no evidence was found of latanoprost's blunting the negative effect of H 2 O 2 , and it was toxic at 10 M (Fig. 11) . EGCG at 50 M was also used for comparative purposes as it is known to blunt the negative effect of H 2 O 2 on RGC-5 cells. 40 Staining of dead cell nuclei in cultures with Hoechst 33258 dye confirmed that ACS67 and EGCG attenuate H 2 O 2 -induced toxicity to RGC-5 cells (Fig. 12) . It is clear in Figure 12 that the number of stained nuclei induced by H 2 O 2 toxicity were much reduced in the presence of 10 M ACS67 or 50 M EGCG.
Further support of the effectiveness of ACS67 as a neuroprotectant was provided by staining of cultures for apoptosis (APOPercentage method; Biocolor; Fig. 13 ). After exposure to 200 M H 2 O 2 , several cells died by apoptosis, as evidenced by membrane changes resulting in the staining of phosphatidylserine. It can be seen in Figure 13 that 10 M ACS67 or 50 M EGCG blunted the effect of H 2 O 2 , with ACS67 being more effective. Cells were also stained for ROS (Fig. 14) detected in cell nuclei after H 2 O 2 insult. This H 2 O 2 -induced production of ROS is significantly reduced by 10 and 50 M of ACS67 and EGCG, respectively.
Exposure of RGC-5 cells to ACS67 (1 and 10 M), ACS1 (1 and 10 M), EGCG (100 M), or latanoprost (10 M) for 8 FIGURE 6. Caspase 3 and -8 mRNA levels relative to cyclophilin (cyclo) mRNA in nonischemic retina (control) and after ischemia-reperfusion with treatment of vehicle (ischemia) or ACS67 (ischemiaϩACS67). Ischemia-reperfusion caused significant elevation of the mRNA level in vehicle-treated animals, but these changes were not significantly blunted by treatment with ACS67. Data are expressed as the mean; error bar, ϮSEM (n ϭ 12 in each case; **P Ͻ 0.01).
FIGURE 5.
NF-L and Thy-1 mRNA levels relative to cyclophilin (cyclo) mRNA in nonischemic retina (control) and after ischemia-reperfusion with treatment of vehicle (ischemia) or ACS67 (ischemiaϩACS67). Ischemia-reperfusion caused a significant decrease in the mRNA level in vehicle-treated animals. These changes were significantly blunted by treatment with ACS67 by 21% and 19% for NF-L and Thy-1, respectively. Data are expressed as the mean; error bar, ϮSEM (n ϭ 12 in each case; **P Ͻ 0.01, ***P Ͻ 0.001).
hours showed that ACS67, ACS1, and EGCG caused a significant elevation of measured GSH, whereas latanoprost was without effect (Fig. 15) . Of interest was the finding that the lower concentrations of ACS67 and ACS1 (1 M) were more effective than a 10-times greater concentration in causing an elevation of GSH in RGC-5 cells.
DISCUSSION
In this study, ACS67, a derivative of latanoprost acid, acted as a neuroprotectant counteracting an ischemic-reperfusion insult to the retina and an oxidative insult to RGC-5 cells in culture. As shown in Figure 1 , ACS67 is an ester of latanoprost acid containing dithiolethione (ACS1) and is likely to be hydrolyzed in vitro or in vivo to the parent compounds. ACS1 has been demonstrated to release H 2 S in vitro when incubated with rat liver homogenates. 3 Moreover, ACS1 esters containing diclofenac (ACS15) or aspirin (ACS14) are known to release H 2 S in vitro and in vivo.
2, 31 We therefore propose that the neuroprotective action of ACS67 is due to the H 2 S release from the sulfurated moiety as found for ACS1, ACS14, and ACS15. Moreover, the finding that ACS67 stimulates the production of FIGURE 7. GFAP and PARP mRNA levels relative to cyclophilin mRNA in nonischemic retina (control) and after ischemia-reperfusion with treatment of vehicle (ischemia) or ACS67 (ischemiaϩACS67). Ischemia-reperfusion caused significant elevation of the mRNA level in vehicle-treated animals but these changes were only significantly blunted for GFAP (31%) by treatment with ACS67. Data are expressed as the mean. Error bars, ϮSEM (n ϭ 12 in each case, ***P Ͻ 0.001, *P Ͻ 0.05). GSH in cultured cells (Fig. 15 ) and in the aqueous humor when applied topically to the rabbit eye 2 provides support for this notion. H 2 S is known to stimulate GSH formation 9, 42 as well as other processes that could contribute to a neuroprotective action. 5, 19 This study provided electrophysiological, immunohistochemical, and biochemical data to show that ACS67 counteracted an insult of ischemia-reperfusion to the retina in situ. We conclude that this is because of the release of H 2 S released from ACS67, although this requires confirmation, as already demonstrated for diclofenac (ACS15) and aspirin (ACS14). Significantly, H 2 S has been shown to attenuate the effects of ischemia to tissues, such as the heart and liver, 4, 18, 24, 25 but not to the brain, where it exacerbates the insult. 27 This study is therefore the first to conclude that H 2 S blunts the influences of ischemia-reperfusion to central nervous system (CNS) tissue. Ischemia to the retina was induced by elevation of the IOP above the systolic blood pressure for 50 minutes and vehicle or ACS67 injected into the vitreous humor. Of importance, the reduction of the a-and b-wave amplitudes of ERGs in vehicletreated rats was significantly greater than in animals treated with ACS67. Thus, the electrophysiological data suggest that physiological damage to the retina induced by ischemia-reperfusion is attenuated by ACS67. 43 In the model of ischemia-reperfusion used in this study, it is known that the inner retina is particularly affected 44 as demonstrated in this study by a reduction in nNOS and Thy-1 immunoreactivity in different subsets of amacrine and ganglion cells in the inner retina. In contrast, GFAP immunoreactivity in glial cells was clearly enhanced by the insult. It should be emphasized that it is important for sections of similar eccentricities to be compared when making comparisons between different retinas. However, by comparing sections from approximately the same retinal areas in a masked fashion, it is possible to make an informed judgment. We concluded that nNOS, Thy-1, and GFAP immunoreactivity are much affected by ischemia-reperfusion and that the changes are blunted by intravitreal administration of ACS67.
Analysis of the level of retinal mRNAs and proteins in the retina and optic nerve of rats subjected to ischemia corroborated the data derived by immunohistochemistry and electrophysiology. The degree of ganglion cell death after ischemiareperfusion was determined by relating the protein (NF-L) and mRNA (Thy-1 and NF-L) levels of ganglion cell-specific markers with total actin protein and cyclophillin mRNA levels, respectively, in each retinal sample. The validity of this method of obtaining information on ganglion cell death is documented in various publications. 33, 34, 45 The results show that ischemiareperfusion has a drastic effect on ganglion cells, causing a large decrease in NF-L mRNA/protein and Thy-1 mRNA levels. This effect is significantly blunted by injection of ACS67.
NF-L and tubulin proteins are present in ganglion cells and analysis of their levels in the optic nerve provides a measure of ganglion cell viability. 46, 47 Ischemia-reperfusion clearly reduces the levels of tubulin and NF-L proteins in the optic nerve, as well as NF-L in the retina, which are significantly blunted by ACS67. Thus, ischemia-reperfusion causes both a reduction in retinal mRNA/proteins and optic nerve proteins associated with ganglion cells and this effect is nullified by intravitreal injection of ACS67.
GFAP is associated with retinal glial (astrocytes and Müller cells), and when these cells are activated by ischemia, the expression of GFAP is upregulated. 48 It remains unknown exactly why this occurs. In these studies, GFAP protein and mRNA are upregulated after ischemia-reperfusion. This finding is consistent with our present immunohistochemical results and with other published data showing that GFAP immunoreactivity in retinal Müller cells is enhanced after ischemia-reperfusion. 48 -50 Significantly, ACS67 attenuates ischemia-reperfusion-induced upregulation of Müller cell GFAP protein and mRNA.
Various studies have shown that retinal neuronal death caused by ischemia-reperfusion occurs by apoptosis. 44, 51 Evidence of cell death was substantiated in the present study, where it was shown that caspase 3 mRNA, caspase 8 mRNA, and PARP mRNA/protein were upregulated in the retina after ischemia-reperfusion. During apoptosis, caspase 3, caspase 8, and PARP are known to be upregulated. [52] [53] [54] [55] The finding that ACS67 significantly attenuated the upregulation of PARP protein caused by ischemia-reperfusion provides further evidence that ACS67 is a neuroprotective agent. It is difficult to explain the lack of effect of ACS67 on the upregulation of caspase 3, caspase 8, and PARP mRNAs caused by ischemia-reperfusion. A possible explanation is that ischemiareperfusion caused too great an elevation of caspase 3 and -8 and PARP mRNAs and that the positive influence of ACS67 was not sufficient to be detected.
With the transformed neuronal precursor cell line (RGC-5), 56 we showed H 2 O 2 -induced cell apoptosis to be attenuated by ACS67, ACS1, and EGCG. In contrast, latanoprost was ineffective. Oxidative stress caused by H 2 O 2 and apoptosis was indicated by an increase in intracellular ROS and the staining of cell membranes for phosphatidylserine or DNA (APOPercentage; [Biocolor] or Hoechst dye, respectively). These data are consistent with our view that the neuroprotective effect of ACS67 and ACS1 is caused specifically by the release of H 2 S from the molecule. In contrast, although EGCG is known to attenuate the negative effect of H 2 O 2 to RGC-5 cells, 57 it has not been suggested to date that the neuroprotective action of EGCG involves such a process. 58 It has been demonstrated that H 2 S is effective in counteracting an insult of oxidative stress on cells in culture. 19, 22, 42 In our results, ACS67, ACS1, and EGCG stimulated GSH formation in RGC-5 cells. It is known that EGCG can affect GSH metabolism, but how this occurs remains undefined. 59 -62 In contrast, there is evidence to suggest that intracellular cysteine levels are enhanced indirectly to form GSH by H 2 S stimulation of glutamate/cysteine antiporters and ␥-glutamylcysteine activity. 9 We therefore suggest that H 2 S released from ACS67 or ACS1 is the cause of the elevation of GSH in RGC-5 cells that occurred in our study within an 8-hour period. Of importance, in analyses was conducted after 24 hours, little enhancement of GSH content was evident (data not shown). Moreover, we consistently found that the lower concentration (1 M) of ACS1 and ACS67 enhanced GSH content to a greater extent than the higher concentration (10 M). This observation was surprising, and we have no explanation for it, especially since H 2 S, as a sulfhydryl compound, has reducing properties similar to those of GSH. 42 We therefore conclude that ACS67 and ACS1 attenuate, at least partially, the process of oxidative-induced RGC-5 cell death by the release of H 2 S, causing an elevation of GSH. Although there is impressive evidence to show that raising intracellular GSH can influence oxidative stress and consequently counteract apoptosis, 42, [63] [64] [65] it cannot be concluded from these studies that the neuroprotective effects of ACS67 and ACS1 are solely the result of their action on GSH. The actual process by which ACS67 and ACS1 act as neuroprotectants probably involves several mechanisms that are affected by H 2 S and not solely by a stimulation of GSH. Other mechanisms by which H 2 S has been shown to have a distinctive action includes the activation of ATP-dependent K ϩ (K ATP ) and Cl Ϫ channels, postulated to be caused indirectly by oxidative stress on immortalized hippocampal cells. 9, 19 It has also been observed that H 2 S protects astrocytes from injury caused by H 2 O 2 by promoting glutamate uptake and in the process decreasing ROS generation, enhancing ATP production, and suppressing ERK1/2 activation. 22 Moreover, H 2 S stimulates adenylate cyclase and in the process modulates intracellular mechanisms 42 that could attenuate defined death mechanisms in neurons.
Our studies clearly show that latanoprost does not counteract H 2 O 2 -induced loss of RGC-5 cell viability in culture. This observation provides support for the notion that the neuroprotective characteristics of ACS67 are associated with the release of H 2 S from the sulfurated moiety of latanoprost rather than with latanoprost itself. However, three publications have appeared that show latanoprost has neuroprotective properties. In the first study, latanoprost was shown to protect retinal cells in situ (ischemia) and in vitro (glutamate toxicity) by influencing cyclo-oxygenase and nitric oxide synthase activity. 66 The second study reported that ganglion cell death induced by axotomy or injection of NMDA into the vitreous humor are blunted by administration of latanoprost. 67 In the third study, latanoprost was reported to attenuate glutamate/BSO death to RGC-5 cells. 68 These authors also demonstrated that topical application of latanoprost attenuates retinal ganglion cell death in situ initiated by optic nerve crush. 68 We have no obvious explanation for finding no evidence to suggest that latanoprost acted as a neuroprotectant when RGC-5 cells are insulted by oxidative stress caused by H 2 O 2 (Fig. 11) . One possibility is that latanoprost may in some way be rendered inactive in the presence of H 2 O 2 .
The conclusion reached from our study is that ACS67 is likely to be rapidly hydrolyzed in situ or in vitro to release H 2 S, which has neuroprotective properties and results in an attenuation of the negative effects of retinal ischemia or an oxidative insult to RGC-5 cells in culture.
